Shareholders Equity: The sum of preferred and common equity items.
Cognition Therapeutics, Inc. (CGTX) had Shareholders Equity of $24.47M for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-8.14M |
|
-- |
|
-- |
|
$15.19M |
|
$-15.19M |
|
$7.05M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-15.19M |
|
$-15.12M |
|
30.03M |
|
30.03M |
|
$-0.27 |
|
$-0.27 |
|
Balance Sheet Financials | |
$34.22M |
|
$0.28M |
|
$0.94M |
|
$35.16M |
|
$10.17M |
|
-- |
|
$0.52M |
|
$10.69M |
|
$24.47M |
|
$24.47M |
|
Shareholders Equity |
$24.47M |
32.16M |
|
Cash Flow Statement Financials | |
$-16.02M |
|
$-0.15M |
|
$4.52M |
|
$41.56M |
|
$29.92M |
|
$-11.64M |
|
$4.35M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.26% |
|
-33.26% |
|
-23.15% |
|
-33.26% |
|
$0.76 |
|
$-0.54 |
|
$-0.53 |